Assessment of diagnostic tests.

Abstract:

:An increasing number of clinicians is to day aware of the need to assess their diagnostic tools. Despite the fact that monetary value is only one of the components of the cost of a diagnostic test, economical problems are decisive stimuli for such an effort. Any diagnostic test involves a cost which is borne by the patient. So, test request is admissible only if its result may provide an useful information to the clinician. Behind this apparently simple formulation, one can foresee difficulties arising from the fact that criteria of judgement are essentially subjective, both for the cost and the usefulness. Several indices such as sensitivity, specificity, predictive values and accuracy, are commonly used for the assessment of the diagnostic value of a test. But these indices are not always calculated from valid data. And biases and lack of precisions are sometimes an obstacle to the transferability of the conclusions. Running from the most simple to the most complex, the aim of the assessment may be: 1. To judge the diagnostic value of a single test by reference to the final diagnosis or to the clinician's initial hypothesis. 2. To compare two diagnostic tests A and B and to discuss the possible interest of their combination. 3. To define the exact place of a test in a complex diagnostic strategy. In each of these situations, an ideal protocol can be envisaged. It will be often difficult to apply. But it will help to an informative description of both data and results, making easier utilisation of the conclusions of the study by the whole medical community.

journal_name

Bull Cancer

journal_title

Bulletin du cancer

authors

Alperovitch A

subject

Has Abstract

pub_date

1980-01-01 00:00:00

pages

376-83

issue

4

eissn

0007-4551

issn

1769-6917

journal_volume

67

pub_type

临床试验,杂志文章
  • The physician data query (PDQ) cancer information system.

    abstract::PDQ is an online database that provides information about the prognosis and treatment of all major types of cancer. It represents a major effort by the NCI to communicate advances in cancer treatment using computer technology, and serves as a major component of the Institute's program to reduce cancer mortality nation...

    journal_title:Bulletin du cancer

    pub_type: 临床试验,杂志文章

    doi:

    authors: Hubbard SM

    更新日期:1987-01-01 00:00:00

  • [Innovation in radiotherapy: A glance at 2018].

    abstract::Innovation in radiotherapy should meet multiple challenges, both technically, biologically, clinically and socially. Scientific, technological and biological advances have resulted in major changes in the implementation, indications, and therapeutic index of radiotherapy over the last century. Based on technical innov...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2018.12.006

    authors: Vial N,Vallard A,Jmour O,Rehailia-Blanchard A,Ben Mrad M,Trone JC,Daguenet E,Guy JB,Magné N

    更新日期:2019-01-01 00:00:00

  • [TRP calcium channel and breast cancer: expression, role and correlation with clinical parameters].

    abstract::Breast cancer (BC) has the highest incidence rate in women in industrialized countries. Statistically, it is estimated that one out of 10 women will develop BC during her life. Evidence is accumulating for the role of ion channels in the development of cancer. Most studied ion channels in BC are K(+) channels, which a...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2012.1595

    authors: Ouadid-Ahidouch H,Dhennin-Duthille I,Gautier M,Sevestre H,Ahidouch A

    更新日期:2012-06-01 00:00:00

  • Antitumoral activity of dipyrido [4,3-b] [3,4-f] indoles on L 1210 leukemia.

    abstract::Newly synthesized dipyrido [4,3-b] [3,4-f] indole compounds have a structural similarity with the DNA intercalating agents ellipticines (pyrido-carbazoles). The procedure of synthesis of these compounds allows the addition of a lateral chain in position 1 of the nucleus. Comparison is made between different substituti...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Lidereau R,Chermann JC,Gruest J,Montagnier L,Ducrocq C,Rivalle C,Bisagni E

    更新日期:1980-01-01 00:00:00

  • [Radiotherapy for sarcoma: hadrontherapy, for whom and what for?].

    abstract::The radiobiological properties of the hadrons (neutrons, protons, carbon ions) led to their therapeutic use in sarcomas, as a referent therapy or as an alternative to photon therapy. An extensive review of the literature has been conducted to assess the present indications and the perspectives for hadrontherapy. Compa...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2010.1125

    authors: Pommier P,Sunyach MP,Hu Y,Amsalem E,Claude L,Moncort-Boulch D,Toutenu P,Balosso J

    更新日期:2010-06-01 00:00:00

  • [Mechanisms and role of lymphangiogenesis in cancer metastasis].

    abstract::An important critical point in tumor progression is the acquisition of metastatic potential. The presence of metastases in regional lymph nodes is an indicator of poor survival. The vascular endothelial growth factor (VEGF) family of growth factors and receptors is involved in vasculogenesis and angiogenesis. Among th...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Dupuy E,Tobelem G

    更新日期:2003-07-01 00:00:00

  • [The surrogate: Partner in the shared decision-making].

    abstract:UNLABELLED:The legislative process of the surrogate appears to be unclear to health professionals and to patients and next of kin. To better adapt this process to the clinical practice our objective was here to document how the persons designated as surrogate perceived their role and how they described the difficulties...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2016.03.003

    authors: Sarradon-Eck A,Capodano G,Bureau E,Julian-Reynier C

    更新日期:2016-07-01 00:00:00

  • [Protontherapy: basis, indications and new technologies].

    abstract::With over 70,000 patients treated worldwide, protontherapy has an evolution on their clinical applications and technological developments. The ballistic advantage of the Bragg peak gives the possibility of getting a high conformation of the dose distribution to the target volume. Protontherapy has accumulated a consid...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2010.1149

    authors: Mazal A,Habrand JL,Delacroix S,Datchary J,Dendale R,Desjardins L,Ferrand R,Malka V,Fourquet A

    更新日期:2010-07-01 00:00:00

  • [Registry of cancers of the upper respiratory and digestive tract at the Northern and Pas-de-Calais departments from 1984 to 1986].

    abstract::Northern France is known to have the highest mortality rate for cancers of the upper aerodigestive tract (UADT); a UADT cancer registry was therefore set up in this region in January 1984. Three years of meticulous registration provided some significant information. The incidence of UADT cancer was alarming: 4538 UADT...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Adenis L,Lefebvre JL,Cambier L

    更新日期:1988-01-01 00:00:00

  • [MDR (Multiple Drug Resistant) type of resistance to chemotherapy in clinical practice].

    abstract::Multifactorial resistance is the main mechanism of chemotherapy failure in cancers. Multidrug resistance (MDR) is related to the expression of a 170 kDa membrane glycoprotein, the so-called P-glycoprotein (P-gp). This protein is able to extrude drugs of various structures and mechanisms out of the cytoplasm. P-gp is a...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Oudard S,Marie JP,Pujade Lauraine E

    更新日期:1996-08-01 00:00:00

  • [Role of psychological factors in cancerogenesis and the development of cancerous disease].

    abstract::Psychoanalysts working in cancerology have to face three main difficulties concerning their methodology: the selection of representative populations, the identification of prospective factors and the choice and definition of the data they need to collect. Four examples are given hereafter: a prospective study on the p...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Raimbault E

    更新日期:1986-01-01 00:00:00

  • [Can we enhance the one-day part in breast conservative surgery?].

    abstract:INTRODUCTION:French national guidelines lead us to increase the part of one-day breast cancer conservative surgery. Our objective was to check if we can enhance our outpatient part and to identify solutions to improve our practices. METHODS:From 01/01/2013 to 31/12/2014, we conducted a monocentric and retrospective re...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2015.09.010

    authors: Gachon B,Nadeau C,Fritel X

    更新日期:2015-12-01 00:00:00

  • Evaluation of multidrug resistant phenotype by flow cytometry with monoclonal antibodies and functional tests.

    abstract::Multidrug resistant (MDR) phenotype is characterized by a defect in drug accumulation caused by overexpression of a transmembrane glycoprotein, the P-glycoprotein (P-gp). MDR phenotype can be characterized either with monoclonal antibodies raised against P-gp or with functional tests, most often based on the incorpora...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Lizard G,Maynadié M,Roignot P,Lizard-Nacol S,Poupon MF

    更新日期:1995-03-01 00:00:00

  • [Gangliosides and cancer].

    abstract::Gangliosides are glycosphingolipids which contain neuraminic acid. Although they are present in the plasma membranes of all cells, gangliosides are expressed differently, both quantitatively and qualitatively, in certain types of cancer. Modifications in ganglioside composition may account for some of the abnormal int...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Dumontet C,Portoukalian J

    更新日期:1991-01-01 00:00:00

  • A phase I-II, dose-escalating trial of ZD9331 in combination with irinotecan (CPT11) in previously pretreated metastatic colorectal cancer patients.

    abstract:BACKGROUND:To establish the recommended dose (RD) of the thymidylate-synthase inhibitor ZD9331 administered with irinotecan (CPT-11) in patients with pretreated metastatic colorectal cancer, and to assess toxicity profile, pharmacokinetics (PK), and anti-tumor activity in a phase I/II open, multicenter, intrapatient ch...

    journal_title:Bulletin du cancer

    pub_type: 临床试验,杂志文章,多中心研究

    doi:

    authors: Louvet C,André T,Gamelin E,Garcia ML,Saavedra A,Lenaers G,de Gramont A,Méry-Mignard D,Kalla S

    更新日期:2004-12-01 00:00:00

  • [Squamous cell anal carcinoma. What's next ?]

    abstract::Despite its status as a rare disease, the incidence of the squamous cell carcinoma of the anus (SCCA) is surging, especially in its metastatic form. In addition, the prognosis of initially localized diseases has not substantially changed since the 1970s with a recurrence rate of between 25-40 % after the chemoradiothe...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2020.12.001

    authors: Kim S,Spehner L,Cabel L,Bidard FC,Borg C

    更新日期:2021-01-01 00:00:00

  • [Withholding and withdrawal decisions in oncology: legal frame and practice].

    abstract::Whereas medicine is progressing in illness treatment that used to be incurable, physicians are still faced with treatment failure. Hippocrates used to say: "primum non nocere" [1]. When the patient cannot expect benefit from potentially aggressive care, current or possible treatments have to be challenged to leave jus...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2009.0910

    authors: Laude C,Deygas S

    更新日期:2009-07-01 00:00:00

  • ARLTS1, potential candidate gene in familial aggregation of hematological malignancies.

    abstract:INTRODUCTION:Genetic predisposition to familial hematological malignancies was previously described through several epidemiological analyses, but the genetic basis remains unclear. The tumor-suppressor ARLTS1 gene was previously described in sporadic hematological malignancies and familial cancer context. METHODS:In t...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2016.10.016

    authors: Hamadou WS,Besbes S,Mani R,Bourdon V,Ben Youssef Y,Achour B,Regaieg H,Eisinger F,Mari V,Gesta P,Dreyfus H,Bonadona V,Dugast C,Zattara H,Faivre L,Noguchi T,Khélif A,Sobol H,Soua Z

    更新日期:2017-02-01 00:00:00

  • [Decision making process in oncology: rationale and delineation of a composite index of relative antitumoral efficacy (In-RATE)].

    abstract::Over the last decade, the development of new therapeutic options has made more patients benefit from antitumoral strategies including several lines of chemotherapy, the aim of which is a long-term control of the disease progression. In such a context of "chronic" management, the choice of tumor response as a single pa...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2008.0738

    authors: Marty M,Blay JY,Trédaniel J,Koscielny S,Hagège C,Asselain B,Goldwasser F,Misset JL

    更新日期:2008-11-01 00:00:00

  • [Particle therapy: carbon ions].

    abstract::Carbon ion therapy is an innovative radiation therapy. It has been first proposed in the forties by Robert Wilson, however the first dedicated centres for human care have been build up only recently in Japan and Germany. The interest of carbon ion is twofold: 1) the very sharp targeting of the tumour with the so calle...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2010.1151

    authors: Pommier P,Hu Y,Baron MH,Chapet O,Balosso J

    更新日期:2010-07-01 00:00:00

  • [Specificities of carcinomas in adolescents and young adults].

    abstract::Carcinomas are rare tumors of the adolescent-young adult (AYA) with a different spectrum from those of adults. The most common sites outside of the thyroid is the nasopharynx, salivary gland, colon-rectum and ovaries. If nasopharyngeal carcinoma or salivary gland tumors are good prognosis, others are more reserved pro...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2016.11.013

    authors: Fresneau B,Dourthe ME,Jouin A,Laurence V,de Lambert G,Colas C,Coret M,Laprie A,Rebours C,Orbach D,Demoor-Goldschmidt C

    更新日期:2017-03-01 00:00:00

  • [Cell adhesion molecules: expression and function in acute myeloid leukemia].

    abstract::Adhesion molecules play a major role in the regulation of normal hematopoiesis. Precursor/cell matrix/endothelial interactions determine retainment or release of hematopoietic cells from the bone marrow microenvironment. Consequently, changes in the affinity or quantitative expression of adhesion molecules on either t...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Thomas X,Anglaret B

    更新日期:1999-03-01 00:00:00

  • [DNA mismatch repair and BRAF status in colorectal cancer: Interest for the therapeutic management?].

    abstract::Colorectal cancer (CRC) is the second leading cause of cancer-related mortality in France. Recently, colorectal cancer subtyping consortium (CRCSC) identified 4 consensus molecular subtypes (CMS). CMS1 is enriched for CRC with deficient DNA mismatch repair system (dMMR) and tumors with mutated BRAF. Intriguingly, CMS1...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/S0007-4551(15)31220-0

    authors: Cohen R,Cervera P,Svrcek M,Dumont C,Garcia ML,Chibaudel B,de Gramont A,Pocard M,Duval A,Fléjou JF,André T

    更新日期:2015-06-01 00:00:00

  • [Breast cancer screening: On our way to the future].

    abstract::Breast cancer remains a potentially lethal disease, which requires aggressive treatments and is associated with long-term consequences. Its prognosis is linked to both tumor biology and burden at diagnosis. Although treatments have allowed important improvements in prognosis over the past 20 years, breast cancer scree...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2016.06.005

    authors: Delaloge S,Bachelot T,Bidard FC,Espie M,Brain E,Bonnefoi H,Gligorov J,Dalenc F,Hardy-Bessard AC,Azria D,Jacquin JP,Lemonnier J,Jacot W,Goncalves A,Coutant C,Ganem G,Petit T,Penault-Llorca F,Debled M,Campone M,Levy

    更新日期:2016-09-01 00:00:00

  • Genetics of rectal cancer.

    abstract::Two operational subdivisions of hereditary colorectal cancer susceptibility are those with and those without premalignant adenomatous colonic polyp expression. In both of these subdivisions, reliable biomarkers of gene carriage would be of value in patient management as we have previously emphasized. Consideration mus...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Lynch HT,Schuelke GS,Lynch JF

    更新日期:1984-01-01 00:00:00

  • [Nab-paclitaxel].

    abstract::Paclitaxel is conventionally used in a wide range of oncology indications. Nab-paclitaxel is synthesized by a process of high pressure homogenization of paclitaxel in the presence of human albumin and it was originally developed to reduce the toxicity usually associated with cremophor in soluble paclitaxel and to incr...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2015.03.020

    authors: Lopez-Trabada Ataz D,Dumont S,André T

    更新日期:2015-06-01 00:00:00

  • [Communication process in consultation of patients with incurable disease: a prospective study].

    abstract::Patients wish to be fully informed about their health, but some information and its disclosure may pose special challenges depending on the severity of the illness. This prospective observational study investigates the content of information about the disease and treatment, as well as the process by which information ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2011.1530

    authors: Marcoux I

    更新日期:2012-02-01 00:00:00

  • [Neoadjuvant approach for non-metastatic rectal cancer combining radiotherapy and chemotherapy. Biotargeted drugs].

    abstract::Neoadjuvant chemoradiotherapy is considered at the present time as the standard treatment of most T3-4 rectal cancer. In France a combination of radiotherapy (45 Gy/5 weeks) with concurrent capecitabine (1,600 mg/m2) is the most popular protocol. Randomized trials try to optimize this approach using new cytotoxic drug...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2009.0838

    authors: Gérard JP,Francois E,Deustch E,Rostom Y,Douar N,Benezery K,Milano G

    更新日期:2009-03-01 00:00:00

  • Pain burden in desmoid tumor patients: a survey of the French Advocacy Group SOS Desmoid.

    abstract:INTRODUCTION:The French Patient Advocacy Group SOS Desmoid conducted a survey to measure the pain burden of desmoid tumor patients. MATERIAL AND METHODS:We used a structured questionnaire to measure the occurrence and consequences of pain. RESULTS:The pain occurrence was approximately 63%. In one-third of the cases, ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2015.02.001

    authors: Rigaux P,Lefebvre-Kuntz D,Penel N,“SOS Desmoïde”.

    更新日期:2015-03-01 00:00:00

  • [Epidemiology and anatomy of head and neck cancers].

    abstract::Oral cavity and pharyngeal cancers account for 75% of head and neck cancers and are the fourth most spread cancer in men. Their incidence has decreased since 1980 in men (incidence from 2011 gives 13,930 for lip, oral cavity, pharyngeal and laryngeal carcinomas) but has increased in women, linked to the more recent sm...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2014.1962

    authors: Périé S,Meyers M,Mazzaschi O,De Crouy Chanel O,Baujat B,Lacau St Guily J

    更新日期:2014-05-01 00:00:00